132 results about "Drug usage" patented technology

A system and method for accurately and reliably determining and recording the time, date and location where a medication is used, and a system and method for transmitting, collecting, and using that data to improve clinical care, disease management, and public health surveillance. The device allows information concerning drug usage, including the time, date and location of use, to be transmitted to a remote network computer system so that the data can be evaluated to determine current impairment and future risk, and to identify changes in the frequency, timing, or location of medication usage indicative of change in disease control or management, and to examine spatial, temporal or demographic patterns of medication use or absence of use among individuals and groups. In addition, the device may further be configured to transmit signals indicative of its status, condition or other results to the remote network computer system.

A system and method are provided for automated and precise administration and documentation of medical drugs. An identification mechanism such as barcodes or RFID technology is incorporated into a syringe that can be loaded into a syringe gun having an appropriate reader. The syringe gun includes or communicates with a control system that can store or communicate with a database comprising drug, patient and inventory information. The information can be used by the control system to control the administration of the drug, provide suitable safeguards based on the nature of the drug and the patient, and to update inventory and initiate billing as required.

The present invention is directed to a device for monitoring the usage of inhaled drugs by a patient. The device includes an inhaler, a use sensor, a microprocessor, a wireless transmitter and a battery compartment. These components allow information concerning drug usage to be transmitted to health care personnel that can evaluate the data to determine whether there are changes in drug usage characteristics that are indicative of an impending acute attack. The invention includes not only the device, but also the systems and methods in which the device is employed.

A system is provided that integrates of records of clinical laboratory services into the assessment and optimization of patient health care and, in particular, regulation of the use of pharmaceuticals. Laboratory test result records are used in conjunction with other health care benefits records to monitor regulation of use of pharmaceuticals by patients. The incorporation of laboratory tests and results into such a utilization system allows improvement in the management of a patient's therapy based on a more precise picture of the patient's level of illness as revealed by the laboratory test results. The system of the present invention also allows optimization of the selection of laboratory tests to be performed, and also provides an outcome assessment of the risk of hospitalization due to pharmaceutical treatments resulting in physician intervention, leading to a change in physician prescribing behavior and, accordingly, a decrease in drug induced hospitalizations and improved quality of patient care and savings of health care costs.

Opiates, amphetamines, barbiturates and other drugs such as benzodiazepines are extensively abused or misused and are frequently the cause of death by overdosing. These drugs are also prone to oxidation and the final degradation products depend on the reactants and the reaction conditions. This invention describes the use of inactivating agents such as permanganates, peroxides, persulfates, bismuthates, periodates or other oxidants in a dosage form as an approach to minimize abuse and overdose. The product is designed such that the inactivating agent is released if there is an attempt to extract the drug from the formulation or in cases of overdose. Once released, the inactivating agent quickly degrades the drug and converts it into inactive compounds. Since the reactants (drug and inactivating agent) are incompatible in situations of normal drug usage, they are kept separated within the vehicle of the invention, but released for interaction in case of misuse. A catalyst may be included in the formulation to facilitate the reaction.

The invention aims at providing an anaesthetic balance control device. The device comprises a data filter module and a drug balance control module. Pre-stored electrocerebral indexes, noxious stimulation data drug usage data are divided into electrocerebral index-sedative data and noxious stimulation data-sedative data. Corresponding drug target control indexes are selected according to electrocerebral index and noxious stimulation data changes in certain period, threshold values are preset, and injection of muscle relaxants are increased or stopped based on the set threshold values. Meanwhile, bispectral index, noxious stimulation data, neuromuscular retarding depth data change tendency slope and the like can be analyzed dynamically, and transverse balance adjusting control is performed on three signals. The invention further provides a work method of the device. According to the device and the method, the problem the imbalanced usage of three drugs is solved, effects of individual differences are prevented, the safety during anesthesia is guaranteed to the largest extent, and good social values and application prospects are provided.

The invention provides a drug dose prediction method and device, electronic equipment and a storage medium, is applied to the technical field of data processing, and can determine more accurate drug use doses for different patients. The method comprises the following steps: acquiring clinical original data of a target patient, wherein the clinical original data comprises demographic information, therapeutic drug use information, drug combination information, adjuvant therapy means, gene polymorphism and inspection information; performing data preprocessing on the clinical original data to obtain target feature data, the data preprocessing including at least one of data cleaning, data normalized coding and data screening; and inputting the target feature data into a drug dose prediction model to obtain the drug dose of the target patient in unit time.

The invention discloses a compound sodium sulfadimidine injection liquid for a pig and a preparation method thereof, aiming at providing a compound kanamycin sulfate injection liquid which has fast effect for treating toxoplasmosis of the pig, addresses both the symptoms and root causes, reduces the time and dosage of used drug and has convenient drug usage, and a preparation method with simple technique and easy implementation. Each 100L injection liquid comprises: 5 to 20 sodium sulfadimidine, 1 to 10kg of lincomycin hydrochloride, 5 to 20kg of doxofylline, 1 to 4kg of trimethoprim, 0.2kg of sodium bisulfite, 0.01kg of EDTA-2Na, 40kg of propylene glycol, 10kg of 95% alcohol and the balance of water for injection. The injection liquid has fast effect for toxoplasmosis of the pig, addresses both the symptoms and root causes, can effectively treat and prevent secondary infection of bacterium, reduces drug resistance of pathogenic microorganism and leads the pig to accelerate restoring. Simultaneously, the compound sodium sulfadimidine injection liquid is an injection liquid and has convenient use.

The invention relates to potassium sodium dehydroandroan drographolide succinate enteric dry suspension and a preparation method thereof. The prepared potassium sodium dehydroandroan drographolide succinate enteric dry suspension comprises, by weight percentage, 5%-50% of potassium sodium dehydroandroan drographolide succinate pellets or particles, 1%-10% of suspending agents and 50%-95% of taste-masked agents. According to the potassium sodium dehydroandroan drographolide succinate enteric dry suspension, the potassium sodium dehydroandroan drographolide succinate is creatively changed from previous injection administration preparations to oral administration preparations, the blanks of domestic and oversea potassium sodium dehydroandroan drographolide succinate oral administration preparations are filled, the untoward effect incidence rate caused by potassium sodium dehydroandroan drographolide succinate injection administration is greatly reduced, administration routes and dosage forms of the potassium sodium dehydroandroan drographolide succinate are enriched, and great value and superiority are provided for clinical rational drug usage. The prepared potassium sodium dehydroandroan drographolide succinate enteric dry suspension is stable in quality, takes effect rapidly, and is good in suspension effect and convenience for the old, children and patients with odynophagia to use.

A method, system, and computer program product for determining a narcotics use indicator to enable a physician, or other prescriber, to quickly review a numerical score that reflects a patient's past drug use and is indicative of proper, or improper, future drug use. This score analyzes many aspects of a patient's past activities to determine multiple individual indicator values that may be selectively weighted to create a final narcotics use indicator. Such individual indicator values may include a usage related indicator factoring in the patient's past drug use, particularly the type of narcotics and controlled substances used; an instruction related indicator that may consider the patient's past use of prescribers, quantity of prescriptions, or the number of open prescriptions from different prescribers; a dispensing related indicator that examines a patient's use of pharmacies, in filling prescriptions; or even an auxiliary indicator that may reflect the patient's number of active prescriptions.

A system and a method for medication identification and inventory control is disclosed. The disclosed system and method were designed to track specified medications' (e.g., narcotics and controlled substances) inventory from manufacturer's lot number all the way to the use/waste stage of the medications and to provide periodic reports and notifications on the medications' usage, breakage, waste and expiration. Further, the disclosed system and method utilizes tamper evident bags with unique identifier to protect and keep accurate track of the medications.

The invention discloses a compound sulfamethoxazole dispersible tablet and a preparation method thereof. The dispersible tablet is characterized in that the compound sulfamethoxazole dispersible tablet prescription comprises the following components in parts by weight: 360-500 parts of sulfamethoxazole, 50-100 parts of trimethoprim, 360-420 parts of a filler, 80-120 parts of a disintegrating agent, and 3-5 parts of a lubricant. The compound sulfamethoxazole dispersible tablet has the advantages of scientific formula, simple process, rapid disintegration of preparation, good dissolution rate, cheap and easily available auxiliary materials, and low cost; the tablet is suitable for large scale production, and can reduce drug usage burden of patients.

The invention discloses a composite insecticidal composition containing dinotefuran and chlopyrifos and purpose thereof. The insecticidal composition contains main effective components of dinotefuran and chlopyrifos in a mass ratio of 0.1-80:0.5-80. The insecticidal composition of the invention can be used for controlling homoptera insects on crops, especially for controlling rice hopper and aphid, can generate efficient synergism, overcome and delay resistance of insects, and has fast insecticidal speed, long persistent period, reduced drug usage cost and an effect obvious better than that of a single dose.

The invention discloses application of all-cannabinoid in preparation of drugs for treating depression. The all-cannabinoid is prepared by uniformly mixing, by weight, 0.3-99.7 parts of an industrial hemp seed extract with 99.7-0.3 parts of industrial cannabinoids. The all-cannabinoid has the obvious relieving effect on the symptoms such as secondary learning memory deterioration of the depression and can be used for preparing the drugs for treating various depression symptoms including endogenous depression, reactive depression, latent depression, secondary depression caused by drugs, climacteric or postnatal depression, depression induced by cerebral trauma or stroke, diabetes-complicated depression and depressive neurosis and used for preparing the drugs for treating the symptoms such as secondary learning memory deterioration and anhedonia which are caused by the depression, and the effect of the all-cannabinoid is better than that of cannabidiol. The all-cannabinoid can be prepared into the clinical drugs of various dosage forms through a conventional preparation method and is convenient to use.

The invention discloses a broiler chicken breeding method. The breeding method comprises the steps that a broiler chicken breeding base is built, wherein the broiler chicken breeding base at least comprises a breeding shed with the area of 1 mu, the breeding density is 4-6/m<2> according to the breeding shed, the breeding shed is divided into two parts, the two parts are connected through a trapezoidal slope, the height of the trapezoidal slope is at least 2 m, the gradient of the slope is 30-45 degrees, a feeding area is arranged on the trapezoidal top surface, the area of the trapezoidal top surface is 1/4 of that of the breeding shed, and facilities in the feeding area comprise a feed feeding trough and a water feeding trough. According to the broiler chicken breeding method, the breeding local area is reasonably planned, the breeding shed and the feeding area are arranged, scientific managing and raising and intensive breeding are conducted, the exercise amount of broiler chickens is increased, the appetite and the feed conversion rate of the broiler chickens can be increased, the immune function of the broiler chickens can be improved, chemical drug usage and drug residues are reduced, and the chicken meat quality of the broiler chickens is improved.

The invention discloses a compound kanamycin sulfate injection liquid for a pig and a preparation method thereof, aiming at providing a compound kanamycin sulfate injection liquid which has fast effect for treating pant disease of the pig, addresses both the symptoms and root causes, reduces the time and dosage of taking drug and has convenient drug usage, and a preparation method with simple technique and easy implementation. Each 100L injection liquid comprises: 5 to 20 billion units of kanamycin monosulfate, 1 to 10kg of lincomycin hydrochloride, 0.1 to 2kg of doxofylline, 0.05kg of dexamethasone sodium phosphate, 0.2kg of sodium bisulfite, 0.01kg of EDTA-2Na, 10kg of dimethyl acetamide and the balance of water for injection. The injection liquid reasonably mixes usage of all the components by a plurality of types of drugs, has fast effect for treating pant disease of the pig, addresses both the symptoms and root causes, reduces drug resistance of pathogenic microorganism and leads the pig to accelerate restoring. Simultaneously, the compound kanamycin sulfate injection liquid has convenient use, and can achieve the treatment effect of a plurality of types of drugs.

The invention discloses a quality control method of a traditional Chinese medicine preparation for treating rheumatism, and specifically provides a quality control method of an activating and pain-relieving capsule. According to the invention, discrimination or content determination is carried out on one or a plurality of bulk drugs in a prescription, such as acanthopanax senticosus, radix clematidis, angelica sinensis, prepared aconite root, prepared kusnezoff monkshood root, radde anemone rhizome, root of red-rooted salvia, processed frankincense, processed myrrh and herbal ephedrae to realize purpose of effective control on product quality. An abstract figure is shown as below. The invention has advantage that the method can carry out discrimination and content determination on a plurality of bulk drugs in the prescription to effectively guarantee drug effect and stability of the produced activating and pain-relieving capsule, thereby better protecting drug usage safety of patients.

The invention discloses an intelligent analysis method, system and device for repeated medication, wherein the method comprises the steps: building a repeated medication database, comparing medicine use information with the related information and rules of the repeated medication database, analyzing the repeated medication condition of a patient, and if repeated medication possibly exists among medicines, evaluating the related rationality and compliance of repeated medication of the patient according to the repeated medication influence of a medicine pair/group possibly having repeated medication and the situation of comprehensive comparative analysis of an original medication scheme and a medication optimization scheme, and generating related application information. Through the method,the system and the equipment for intelligently analyzing the repeated medication, a prescriber is assisted in issuing a more reasonable and compliant medication scheme to a patient, adverse repeated medication is reduced, and the medication safety, effectiveness and economy of the patient are improved.

The invention discloses a drug interaction intelligent management method, system and equipment. The method comprises the steps: building a drug interaction database, comparing drug use information with the related information and rules of the drug interaction database, and analyzing the drug interaction condition of a patient; and if the adverse interaction exists between medicines, generating a medication optimization scheme according to related settings, evaluating the medication interaction related rationality of the patient according to the comprehensive analysis and comparison conditionsof the original medication scheme and the medication optimization scheme, and generating a related medicine interaction comprehensive management result. Through the method, the system and the equipment for intelligently managing the drug interaction, a prescriber can be assisted in issuing a more reasonable and compliant medication scheme to a patient, the adverse drug interaction is reduced, andthe safety, effectiveness and economy of medication of the patient are improved.